Showing results (81-90 of 101) with videos related to
Sort By:
Pageof 11
Lancet (London, England)|November 16, 2004
Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trialDiane M Harper, Eduardo L Franco, Cosette Wheeler, et al.Journal of Synchrotron Radiation|November 3, 2015
A modular and compact portable mini-endstation for high-precision, high-speed fixed target serial crystallography at FEL and synchrotron sourcesDarren A Sherrell, Andrew J Foster, Lee Hudson, et al.International Journal of Cancer|April 15, 2011
Impact of an HPV6/11/16/18 L1 virus-like particle vaccine on progression to cervical intraepithelial neoplasia in seropositive women with HPV16/18 infectionRichard M Haupt, Cosette M Wheeler, Darron R Brown, et al.Clinical and Vaccine Immunology : CVI|April 13, 2007
Noninferiority of antibody response to human papillomavirus type 16 in subjects vaccinated with monovalent and quadrivalent L1 virus-like particle vaccinesSuzanne M Garland, Marc Steben, Mauricio Hernandez-Avila, et al.The Journal of Infectious Diseases|December 15, 2010
External genital human papillomavirus prevalence and associated factors among heterosexual men on 5 continentsEftyhia Vardas, Anna R Giuliano, Stephen Goldstone, et al.The Journal of Infectious Diseases|December 15, 2010
Prevalence of and risk factors for human papillomavirus (HPV) infection among HIV-seronegative men who have sex with menStephen Goldstone, Joel M Palefsky, Anna R Giuliano, et al.Journal of Synchrotron Radiation|September 5, 2018
The scanning four-bounce monochromator for beamline I20 at the Diamond Light SourceShusaku Hayama, Graham Duller, John P Sutter, et al.The New England Journal of Medicine|May 15, 2007
Quadrivalent vaccine against human papillomavirus to prevent anogenital diseasesSuzanne M Garland, Mauricio Hernandez-Avila, Cosette M Wheeler, et al.CA: a Cancer Journal for Clinicians|January 24, 2007
American Cancer Society Guideline for human papillomavirus (HPV) vaccine use to prevent cervical cancer and its precursorsDebbie Saslow, Philip E Castle, J Thomas Cox, et al.Lancet (London, England)|May 22, 2007
Efficacy of a quadrivalent prophylactic human papillomavirus (types 6, 11, 16, and 18) L1 virus-like-particle vaccine against high-grade vulval and vaginal lesions: a combined analysis of three randomised clinical trialsElmar A Joura, Sepp Leodolter, Mauricio Hernandez-Avila, et al.Pageof 11